Non-relapse mortality in pediatric acute lymphoblastic leukemia: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Non-relapse mortality in pediatric acute lymphoblastic leukemia: a systematic review and meta-analysis

Published:2012-01-03 Issue:5 Volume:53 Page:878-885
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Blanco Esther,Beyene Joseph,Maloney Anne Marie,Almeida Rowena,Ethier Marie-Chantal,Winick Naomi,Alexander Sarah,Sung Lillian

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2011.639018

Reference17 articles.

1. Trends in childhood cancer incidence in the U.S. (1992–2004)

2. Trends in incidence of childhood cancer in Australia, 1983–2006

3. Recent Research Advances in Childhood Acute Lymphoblastic Leukemia

4. Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia

5. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Upregulation of Insulin-like Growth Factor-I in Response to Chemotherapy in Children with Acute Lymphoblastic Leukemia;International Journal of Molecular Sciences;2024-09-04

2. What are the long-term complications of pediatric ALL treatments and how can they be mitigated? Perspectives on long-term consequences of curative treatment in childhood ALL;Best Practice & Research Clinical Haematology;2022-12

3. Evaluation of circulating renin-angiotensin system components in pediatric patients with acute leukemia: a pilot study;2022-11-22

4. Evaluation of circulating renin-angiotensin system components in pediatric patients with acute leukemia: a pilot study;2022-09-30

5. JAK3 mutations and mitochondrial apoptosis resistance in T-cell acute lymphoblastic leukemia;Leukemia;2022-04-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3